BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14768750)

  • 41. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis.
    Criscitiello C; Golshan M; Barry WT; Viale G; Wong S; Santangelo M; Curigliano G
    Eur J Cancer; 2018 Jul; 97():1-6. PubMed ID: 29734046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conservation treatment intensified with tamoxifen and CAF chemotherapy for subareolar breast cancers.
    Ogawa Y; Nishioka A; Inomata T; Tsuboi N; Hayase N; Fukumoto M; Yoshida S; Tohchika N; Tanaka Y; Kumon M
    Oncol Rep; 1998; 5(6):1337-41. PubMed ID: 9769365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study.
    Denham JW; Hamilton CS; Christie D; O'Brien M; Bonaventura A; Stewart JF; Ackland SP; Lamb DS; Spry NA; Dady P
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):305-13. PubMed ID: 7836084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
    Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer.
    Pierce SM; Recht A; Lingos TI; Abner A; Vicini F; Silver B; Herzog A; Harris JR
    Int J Radiat Oncol Biol Phys; 1992; 23(5):915-23. PubMed ID: 1639653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.
    Olsen JR; Moughan J; Myerson R; Abitbol A; Doncals DE; Johnson D; Schefter TE; Chen Y; Fisher B; Michalski J; Narayan S; Chang A; Crane CH; Kachnic L
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):400-408. PubMed ID: 28463160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer.
    Back M; Ahern V; Delaney G; Graham P; Steigler A; Wratten C;
    Australas Radiol; 2005 Feb; 49(1):39-43. PubMed ID: 15727608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trastuzumab and Hypofractionated Whole Breast Radiotherapy: A Victorious Combination?
    De Santis MC; Bonfantini F; Di Salvo F; Fiorentino A; Riboldi VM; Di Cosimo S; Bianchi GV; Gennaro M; Cosentino V; Sant M; Pignoli E; Valdagni R; Lozza L
    Clin Breast Cancer; 2018 Jun; 18(3):e363-e371. PubMed ID: 28958838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Rischin D; Walpole E; Harvey J; Macintosh J; Ainslie J; Hamilton C; Keller J; Tripcony L
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):156-63. PubMed ID: 11516865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
    Buchholz TA; Theriault RL; Niland JC; Hughes ME; Ottesen R; Edge SB; Bookman MA; Weeks JC
    J Clin Oncol; 2006 Jan; 24(3):361-9. PubMed ID: 16421417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Acute toxicity of breast cancer irradiation with modulated intensity by tomotherapy
    Aoulad N; Massabeau C; de Lafontan B; Vieillevigne L; Hangard G; Ciprian C; Chaltiel L; Moyal É; Izar F
    Cancer Radiother; 2017 May; 21(3):180-189. PubMed ID: 28499662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
    Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
    Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series.
    Corbin KS; Dorn PL; Jain SK; Al-Hallaq HA; Hasan Y; Chmura SJ
    Am J Clin Oncol; 2014 Aug; 37(4):322-6. PubMed ID: 23357972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A population-based study on variations in the use of adjuvant radiotherapy in breast cancer patients].
    Nagel G; Röhrig B; Hoyer H; Füller J; Katenkamp D
    Strahlenther Onkol; 2002 Nov; 178(11):589-96. PubMed ID: 12426669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast Conserving Therapy for Patients With Prior Cosmetic Implant-Based Breast Augmentation: Outcomes and Comparison Against a Matched Cohort.
    Grzywacz VP; Lehrberg AV; Quinn TJ; Zureick AH; Sarvepalli N; Oliver LN; Dekhne NS; Dilworth JT
    Clin Breast Cancer; 2024 Apr; 24(3):227-236. PubMed ID: 38185608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.